M. Carlholm

Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial

A. Escribano, A. Tutuncu, I. Löhr, 2006, Current medical research and opinion.

Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics.

P. Venge, O. Zetterström, K. Nikander, 1997, The European respiratory journal.

Genes In The 5-lipoxygenase (5-LO) Pathway : Association With COPD

D. Postma, A. Sims, C. Löfdahl, 2010, ATS 2010.

Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide.

B. Lipworth, P. Williamson, M. Carlholm, 2011, British journal of clinical pharmacology.

Methacholine challenge tests to demonstrate therapeutic equivalence of terbutaline sulfate via different Turbuhaler® devices in patients with mild to moderate asthma: Appraisal of a four-way crossover design.

D. Postma, L. Boulet, P. O'Byrne, 2017, Pulmonary pharmacology & therapeutics.

Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence.

A. Tutuncu, M. Carlholm, T. Polanowski, 2007, International journal of clinical pharmacology and therapeutics.